Silence Therapeutics Enters into Agreement to be Acquired by Merck KGaA, Darmstadt, Germany

Contributed by: Business Wire

Logo

Tags

Oncology

Engineering

Health

Manufacturing

Genetics

Pharmaceutical

Biotechnology

Merck KGaA, Darmstadt, Germany

More Like This

Silence Therapeutics Announces Oversubscribed $120 Million Private Placement

Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering

Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares

Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs

Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Silence Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Silence Therapeutics Achieves $2 Million Research Milestone Payment from Hansoh Pharma Collaboration

Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update